# Elastography Imaging Market > Elastography Imaging Market Research Report: Size, Share, Trend Analysis By Imaging Modality (Ultrasound Elastography, Magnetic Resonance Elastography, Computed Tomography Elastography), By Applications (Liver Diseases, Breast Cancer, Musculoskeletal Disorders, Cardiovascular Diseases), By End Users (Hospitals, Diagnostic Centers, Research Institutes), By Technology (Strain Elastography, shear Wave Elastography, Transverse Wave Elastography) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.16% - **2024:** $ 12.61 Billion - **2025:** $ 14.01 Billion - **2035:** $ 40.37 Billion - **Key Players:** GE Healthcare (US), Philips (NL), Siemens Healthineers (DE), Canon Medical Systems (JP), Hitachi Medical Systems (JP), Esaote (IT), Fujifilm (JP), Mindray (CN), Samsung Medison (KR) **Report ID:** MRFR/MED/6598-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070 --- ## Market Summary ## **Elastography Imaging Market Overview** **As per MRFR analysis, the Elastography Imaging Market Size was estimated at USD 0.86 Billion in 2023. The Elastography Imaging Market Industry is expected to grow from USD 0.94 Billion in 2024 to USD 2.5 Billion by 2035.** **The Elastography Imaging Market CAGR (growth rate) is expected to be around 9.3% during the forecast period (2025 - 2035).** ## **Key Elastography Imaging Market Trends Highlighted** The demand for non-invasive diagnostic techniques, particularly in oncology, liver disease, and cardiovascular disorders, is driving significant growth in the Elastography Imaging Market. The increasing prevalence of chronic diseases and emphasis on early diagnosis are also key factors. This drives the advancement and adoption of elastography imaging technologies across healthcare facilities globally. Additionally, the integration of sophisticated imaging technologies with elastography, such as ultrasound and MRI, improves diagnostic precision. This is a critical factor in the improvement of overall clinical outcomes. There are significant opportunities to be discovered in the global market, particularly in emerging regions where the healthcare infrastructure is undergoing continuous improvement. The market participants are in a favorable position to introduce innovative solutions due to the increasing awareness of advanced imaging techniques and the growing investment in healthcare initiatives. Furthermore, the collaboration between healthcare providers and technological firms has the potential to facilitate the development of elastography systems that are both cost-effective and user-friendly, thereby increasing their accessibility. The trend of incorporating **artificial intelligence (AI)** into elastography imaging has been on the rise in recent years. AI facilitates the improvement of image analysis, thereby enabling the more precise and efficient interpretation of elastography data. This trend represents a transition to a more efficient workflow in diagnostic imaging, which will enhance patient management. Additionally, it is anticipated that the ongoing research to improve elastography techniques will expand their applications in a variety of specialties. Consequently, the Elastography Imaging Market is on the brink of further development, propelled by the necessity for improved patient outcomes and technological advancements. ## **Elastography Imaging Market Drivers** ### **Increasing Prevalence of Liver Diseases** The Elastography Imaging Market Industry is significantly driven by the rising incidence of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD). According to the Global Health Organization, the prevalence of NAFLD has increased over the past decade, affecting approximately 25% of the global population. Such a trend emphasizes the need for reliable non-invasive imaging solutions like elastography, which can precisely assess liver stiffness and fibrosis levels. Organizations such as the American College of Gastroenterology have recognized elastography as a crucial tool for diagnosing and managing liver conditions, further boosting demand in the Elastography Imaging Market Industry. The adaptation of elastography technologies in clinical settings highlights its significance in addressing the rising burden of liver diseases worldwide. ### **Technological Advancements in Imaging Techniques** Innovations in elastography imaging technologies are propelling growth in the Elastography Imaging Market Industry. Recent developments in **ultrasound elastography** and magnetic resonance elastography have enhanced the accuracy and efficiency of liver and breast imaging. Research from established institutions, such as the Radiological Society of North America, indicates that the adoption of these advanced imaging modalities has led to improved patient outcomes by facilitating earlier detection of diseases like cancer and fibrosis. As healthcare providers increasingly implement state-of-the-art elastography equipment, the market is expected to grow, driven by the demand for cutting-edge diagnostic imaging tools. ### **Rising Aging Population** The aging population globally is a key driver for the Elastography Imaging Market Industry. According to the United Nations, by 2050, the global population over 60 years will reach 2 billion, with older adults being more susceptible to chronic diseases requiring precise diagnostic imaging. With conditions such as liver disease, diabetes, and cancers prevalent among the older demographic, the demand for non-invasive imaging methods like elastography is expected to surge. National health services in various regions are investing in elastography technologies to cater to this demographic shift, creating substantial growth opportunities in the market. ### **Growing Awareness and Adoption of Non-invasive Procedures** There is a noticeable trend towards non-invasive medical procedures, significantly impacting the Elastography Imaging Market Industry. Factors such as patient comfort and reduced recovery times drive this shift. Reports by health institutions assert that 75% of patients prefer non-invasive procedures over traditional biopsies, leading to a broader acceptance of elastography as an alternative diagnostic tool. Organizations like the World Health Organization advocate for minimally invasive diagnostic techniques, contributing to the increasing integration of elastography in clinical practice. This growing awareness among healthcare providers and patients regarding the benefits of non-invasive diagnostics is expected to facilitate sustained growth in the elastography imaging sector. ## **Elastography Imaging Market Segment Insights** ### **Elastography Imaging Market Imaging Modality Insights** The Elastography Imaging Market, particularly the Imaging Modality segment, is experiencing notable growth as it caters to the evolving needs of medical diagnostics globally. In 2024, the overall market was valued at USD 0.94 Billion, showcasing the increasing reliance on advanced imaging techniques. These techniques are for assessing tissue elasticity and diagnosing various conditions. The predominant share of this segment is driven by Ultrasound Elastography, which was valued at USD 0.4 Billion in 2024 and demonstrates a significant increase to USD 1.05 Billion by 2035. This sub-segment is crucial as it offers real-time imaging and is widely adopted due to its non-invasive nature and cost-effectiveness. Magnetic Resonance Elastography follows, with a valuation of USD 0.3 Billion in 2024, and is expected to reach USD 0.8 Billion by 2035. Its importance lies in its ability to provide detailed insights into tissue architecture and mechanical properties, which are essential for monitoring liver disease and oncology. Computed Tomography Elastography, although a smaller segment, valued at USD 0.24 Billion in 2024 and projected to reach USD 0.65 Billion by 2035, offers unique advantages. These advantages include assessing tissue stiffness in combination with other CT imaging features. The interplay of these modalities highlights a comprehensive approach to elastography imaging, catering to a wide array of clinical applications. This reinforces the Elastography Imaging Market revenue and its segmentation dynamics. The growth in this market is primarily driven by technological advancements, an increase in the prevalence of chronic diseases, and a growing geriatric population, necessitating effective and efficient diagnostic tools. As these imaging modalities continue to evolve, the Elastography Imaging Market statistics suggest a promising trajectory influenced by ongoing research and development endeavors in the field of medical imaging. The significance of each imaging modality is underscored by its specific applications and advantages, which are vital for enhancing diagnostic accuracy and patient outcomes globally. ### **Elastography Imaging Market Application Insights** The Elastography Imaging Market is expected to play a crucial role in the medical imaging landscape, particularly within the Application segment as it grows towards a valuation of USD 0.94 Billion in 2024. This segment is subdivided into various applications, primarily focusing on conditions such as Liver Diseases, Breast Cancer, Musculoskeletal Disorders, and Cardiovascular Diseases. Each of these fields presents significant healthcare challenges, making elastography a vital tool for clinicians. For example, hepatologists utilize elastography for accurately assessing liver stiffness, thus facilitating early diagnosis of liver fibrosis and cirrhosis. In oncology, elastography aids in the evaluation of breast masses, providing critical insights during the treatment process. **Musculoskeletal Disorders** benefit from elastography as it helps in evaluating soft tissues and joint conditions, enhancing patient management. Moreover, in **Cardiovascular Diseases**, elastography can provide invaluable information regarding arterial stiffness, correlating with heart health. The growing prevalence of these health issues drives the demand for innovative imaging solutions, positioning elastography as a key player in improving patient outcomes. The integration of advanced elastography technologies supports the Elastography Imaging Market growth, addressing the healthcare industry's need for efficient diagnostic tools. ### **Elastography Imaging Market End User Insights** The Elastography Imaging Market is witnessing substantial growth within the End User segment, which encompasses Hospitals, Diagnostic Centers, and Research Institutes. In 2024, the overall market reached a valuation of USD 0.94 Billion. Hospitals are crucial players in this space due to their high patient influx and demand for advanced diagnostic imaging solutions, showcasing the significant role they play in utilizing elastography for accurate evaluations of tissue stiffness. Diagnostic Centers further enhance the market landscape as they specialize in a range of imaging services, thereby driving the need for elastography applications in both routine and specialized diagnostics. Research Institutes contribute to the market's evolution by conducting essential studies that pave the way for innovations in elastography techniques, ultimately leading to improved clinical outcomes. The widespread adoption of elastography imaging across these End Users reflects a growing recognition of its benefits in diagnosis, treatment planning, and monitoring, affirming its importance in the Elastography Imaging Market industry. As the market progresses, the continuous advancements in technology, combined with an increasing prevalence of chronic diseases, are expected to further propel demand in this sector, thus shaping the overall Elastography Imaging Market segmentation. ### **Elastography Imaging Market Technology Insights** The Elastography Imaging Market is experiencing significant growth, particularly within the Technology segment, where advancements are leading to enhanced diagnostic capabilities. In 2024, the market was valued at USD 0.94 Billion, with a robust expected growth trajectory leading to USD 2.5 Billion by 2035. This growth is driven by an increasing demand for non-invasive diagnostic techniques across various medical fields. Strain Elastography is noteworthy for its ability to quantify tissue stiffness, facilitating the detection of liver diseases and tumors, thus accounting for a substantial portion of the market. **Shear Wave Elastography** is gaining prominence due to its superior accuracy and ability to provide real-time imaging, making it indispensable in musculoskeletal applications. Additionally, Transverse Wave Elastography is emerging, showcasing its potential in the assessment of breast lesions, thereby enhancing imaging protocols. The continual evolution of technology and techniques in the Elastography Imaging Market is vital in improving patient outcomes and enhancing clinical decisions. With innovative applications and robust adoption rates, the market is poised for sustained growth driven by advancing medical technology and increasing healthcare investments globally. ### **Elastography Imaging Market Regional Insights** The Elastography Imaging Market is expanding steadily, with the overall market reaching a valuation of USD 0.94 Billion in 2024. **North America** holds a significant share, valued at USD 0.4 Billion in 2024 and projected to grow to USD 1.05 Billion by 2035, mainly due to advanced healthcare infrastructure and high adoption of innovative technologies. Europe follows with a valuation of USD 0.25 Billion in 2024 and is expected to reach USD 0.65 Billion by 2035, reflecting a strong emphasis on research and development activities in the medical imaging field. Meanwhile, the **Asia Pacific region** is also gaining traction with a valuation of USD 0.2 Billion in 2024, projected to grow to USD 0.5 Billion by 2035, driven by increasing healthcare investments and rising awareness of elastography's diagnostic capabilities. In South America, the market value stands at USD 0.05 Billion in 2024, with growth anticipated to USD 0.15 Billion by 2035, highlighting a growing demand for non-invasive imaging techniques. Lastly, the Middle East and Africa exhibit a smaller market share, with a valuation of USD 0.04 Billion in 2024, projected to expand to USD 0.15 Billion by 2035, as these regions are gradually embracing advanced medical technologies. The diverse regional dynamics and market growth highlight the substantial potential within the Elastography Imaging Market, influenced by technological advancements and increasing applications across various healthcare sectors. ## **Elastography Imaging Market Key Players and Competitive Insights** The Elastography Imaging Market is characterized by a dynamic landscape driven by advancements in imaging technology, increasing demand for non-invasive diagnostic methods, and a growing emphasis on efficient healthcare delivery. This market has garnered significant attention due to its role in enhancing the diagnosis and monitoring of various medical conditions, particularly those related to the liver and musculoskeletal issues. Competitive insights into this sector reveal a mix of established players and innovative newcomers, all striving to leverage cutting-edge technology and strategic partnerships to secure their positions. As the market evolves, players are focusing on expanding their product offerings, enhancing interoperability, and improving user experience to meet the diverse needs of healthcare providers worldwide. Samsung Medison has made a significant impact in the Elastography Imaging Market with its robust portfolio of ultrasound solutions that integrate elastography applications. The company's strength lies in its commitment to research and development, ensuring that its imaging technologies remain at the forefront of innovation. With a strong emphasis on improving healthcare outcomes through advanced diagnostic capabilities, Samsung Medison has established a broad market presence across various regions. The company prioritizes user-friendly interfaces and customizable features in its products, enhancing the experience for healthcare professionals. As a result, Samsung Medison continues to maintain a competitive advantage by providing reliable and effective solutions that address the evolving needs of the healthcare industry. Bracco Imaging plays a crucial role in the Elastography Imaging Market, known for its expertise in contrast media and advanced imaging solutions. The company offers a suite of diagnostic imaging products, including elastography modalities, that are essential for enhancing diagnostic accuracy. Bracco Imaging's strengths lie in its strong market presence, built on a foundation of high-quality products and a commitment to innovation. The organization has strategically pursued mergers and acquisitions to bolster its capabilities and expand its global footprint. By continually investing in research and development, Bracco Imaging is able to introduce cutting-edge technologies, which place it in a favorable position within the competitive landscape. Through its dedication to improving patient outcomes and collaboration with healthcare professionals, the company solidifies its role as a key competitor in the elastography imaging sector. ### **Key Companies in the Elastography Imaging Market Include** - Samsung Medison - Bracco Imaging - Hitachi - Esaote - Fujifilm - Mindray - Acuson - GE Healthcare - Canon Medical Systems - Siemens Healthineers - Hologic - Terason - Philips - Voluson - SuperSonic Imagine ## **Elastography Imaging Market Industry Developments** The Elastography Imaging Market has seen significant developments recently, particularly with advancements in ultrasound technologies from companies such as Samsung Medison and Siemens Healthineers. In September 2023, GE HealthCare did indeed enhance its ultrasound portfolio's elastography capabilities. The company illustrated improvements to its LOGIQ E10 and Venue Go systems, which incorporate sophisticated 2D shear wave and strain elastography technologies to facilitate liver, breast, and musculoskeletal evaluations. GE HealthCare's commitment to improving the accuracy of disease detection through the use of non-invasive imaging modalities is reflected in these updates. Through the implementation of the DeepInsight AI engine in its ARIETTA ultrasound systems, Fujifilm has maintained its commitment to enhancing its elastography capabilities. Although AI-driven elastography enhancements were not explicitly announced in September 2023, the company did emphasize them at medical imaging conferences in late 2023, such as RSNA and ECR. Particularly for the quantification of thyroid rigidity and the staging of liver fibrosis, these enhancements are comprised of image optimization algorithms. Esaote unveiled new features in its MyLab X9 and MyLab Sigma ultrasound platforms in July 2023. These features were designed to improve real-time elastography for liver and musculoskeletal applications. With an emphasis on high-demand applications such as liver fibrosis staging, Esaote has developed compact, AI-powered ultrasound systems that are designed for hospital and ambulatory use. ## **Elastography Imaging Market Segmentation Insights** ### **Elastography Imaging Market Imaging Modality Outlook** - Ultrasound Elastography - Magnetic Resonance Elastography - Computed Tomography Elastography ### **Elastography Imaging Market Application Outlook** - Liver Diseases - Breast Cancer - Musculoskeletal Disorders - Cardiovascular Diseases ### **Elastography Imaging Market End User Outlook** - Hospitals - Diagnostic Centers - Research Institutes ### **Elastography Imaging Market Technology Outlook** - Strain Elastography - Shear Wave Elastography - Transverse Wave Elastography ### **Elastography Imaging Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Technological Advancements in Imaging Techniques The Global Elastography Imaging Market Industry is experiencing a surge in technological advancements that enhance imaging techniques. Innovations such as shear wave elastography and acoustic radiation force impulse imaging are becoming more prevalent, allowing for improved diagnostic accuracy and patient outcomes. These advancements facilitate the non-invasive assessment of tissue stiffness, which is crucial in diagnosing liver diseases and tumors. As a result, the market is projected to grow from 0.94 USD Billion in 2024 to 2.5 USD Billion by 2035, reflecting a compound annual growth rate of 9.3% from 2025 to 2035. This growth underscores the importance of integrating cutting-edge technology in clinical practice. ## Future Outlook The Elastography Imaging Market is projected to grow at 11.16% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising demand for non-invasive diagnostic techniques. **New opportunities:** - Development of portable elastography devices for remote diagnostics - Integration of AI algorithms for enhanced image analysis - Expansion into emerging markets with tailored elastography solutions By 2035, the Elastography Imaging Market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Liver Imaging (Largest) vs. Breast Imaging (Fastest-Growing) In the Elastography Imaging Market, Liver Imaging holds the largest share, primarily due to the high prevalence of liver diseases, which necessitate advanced imaging techniques for diagnosis and monitoring. This segment dominates the market as a critical tool for non-invasive assessment of liver stiffness, aiding in the management of conditions like hepatitis and cirrhosis. Conversely, Breast Imaging is gaining traction rapidly, driven by increasing awareness of breast cancer and the demand for accurate diagnostic procedures. Healthcare institutions are increasingly adopting elastography techniques for breast tissue analysis, thus contributing to its fast-growing market position. Liver Imaging (Dominant) vs. Breast Imaging (Emerging) Liver Imaging is a dominant segment within the Elastography Imaging Market, largely owing to its established applications in detecting and evaluating liver conditions. Its effectiveness in providing real-time imaging allows for prompt diagnosis and treatment planning, crucial in managing liver-related diseases. On the other hand, Breast Imaging is emerging as a critical segment, propelled by technological advancements and increased screening practices among women. The growing focus on early detection of breast cancer has catalyzed the integration of elastography, enhancing image accuracy and aiding in distinguishing malignant from benign lesions. This evolution is reshaping the landscape of breast health diagnostics. ### By Technology: Ultrasound Elastography (Largest) vs. Magnetic Resonance Elastography (Fastest-Growing) In the Elastography Imaging Market, Ultrasound Elastography holds a prominent position as the largest segment due to its widespread adoption and affordability. It offers non-invasive and real-time assessments of tissue elasticity, making it a preferred choice among clinicians. In contrast, Magnetic Resonance Elastography, though smaller in market share currently, is recognized for its advanced imaging capabilities and precision in assessing liver stiffness, thus catering to specialized segments of healthcare. The growth trends in this market segment are significantly driven by technological advancements and increasing awareness among healthcare professionals regarding the benefits of elastography. As hospitals and clinics continue to invest in state-of-the-art imaging technologies, Magnetic Resonance Elastography is gaining traction, signaling a shift in preference towards non-invasive diagnostic tools. Additionally, the demand for advanced diagnostic procedures, particularly in oncology and hepatology, is further accelerating the growth of this segment. Technology: Ultrasound Elastography (Dominant) vs. Magnetic Resonance Elastography (Emerging) Ultrasound Elastography remains the dominant player in the Elastography Imaging Market, primarily due to its cost-effectiveness, ease of integration into existing ultrasound systems, and ability to provide immediate results. This technology utilizes ultrasonic waves to measure tissue stiffness, supporting various clinical applications, particularly in assessing liver and thyroid conditions. In contrast, Magnetic Resonance Elastography, as an emerging segment, is rapidly gaining popularity due to its high-resolution imaging and capability for evaluating deeper tissue structures. Its application in liver disease assessment is particularly noteworthy as it offers a non-invasive alternative to liver biopsies. As healthcare providers become increasingly cognizant of the advantages these technologies offer in accurate diagnostics, both segments are expected to evolve and capture a greater share of the market. ### By End Use: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing) In the Elastography Imaging Market, hospitals hold the largest share due to their comprehensive imaging services and the high demand for diagnostic procedures. This segment benefits from advanced technology integration and a growing number of elastography imaging procedures performed in clinical settings. Diagnostic imaging centers, on the other hand, are witnessing rapid growth driven by an increasing number of outpatient imaging services and enhancements in patient care standards. This shift is resulting in a substantial increase in the utilization of elastography technologies across these facilities. Hospitals (Dominant) vs. Research Institutions (Emerging) Hospitals are the dominant player in the elastography imaging segment, attributed to their extensive patient volume and the necessity for precise diagnostic capabilities. They utilize advanced elastography technologies to enhance diagnostic accuracy, particularly in liver and musculoskeletal disorders. Conversely, research institutions represent an emerging segment, focusing on innovative applications and research into elastography's effectiveness. While they might not have the same immediate patient throughput as hospitals, their contributions to advancing elastography methodologies and establishing clinical guidelines are significant for future growth. As innovations stem from these institutions, the collaboration between hospitals and research institutions is expected to catalyze the adoption of elastography imaging. ## Regional Market Share Analysis ### North America : Market Leader in Innovation North America continues to lead the Elastography Imaging Market, holding a significant share of 6.3 billion in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of chronic diseases, and rising demand for non-invasive diagnostic techniques. Regulatory support and technological advancements further catalyze market expansion, making it a hub for innovation in medical imaging. The competitive landscape in North America is robust, featuring key players such as GE Healthcare, Siemens Healthineers, and Philips. These companies are at the forefront of developing cutting-edge elastography technologies, enhancing diagnostic accuracy and patient outcomes. The U.S. remains the largest market, supported by substantial investments in healthcare and research, while Canada and Mexico are also emerging as significant contributors to market growth. ### Europe : Emerging Market with Growth Potential Europe's Elastography Imaging Market is valued at 3.8 billion, reflecting a growing demand for advanced imaging solutions. The region benefits from a strong regulatory framework that encourages innovation and adoption of new technologies. Increasing awareness of early disease detection and the rising geriatric population are key drivers of market growth, alongside government initiatives aimed at improving healthcare services. Leading countries in Europe include Germany, France, and the UK, where major players like Siemens Healthineers and Philips are actively investing in research and development. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing product offerings. The European market is poised for growth, driven by technological advancements and a focus on improving patient care. ### Asia-Pacific : Rapidly Growing Market Segment The Asia-Pacific Elastography Imaging Market, valued at 2.8 billion, is experiencing rapid growth due to increasing healthcare expenditure and rising awareness of advanced diagnostic techniques. Countries like China and India are leading this growth, supported by government initiatives to enhance healthcare infrastructure. The demand for non-invasive imaging solutions is on the rise, driven by a growing population and increasing prevalence of chronic diseases. The competitive landscape in Asia-Pacific is evolving, with key players such as Canon Medical Systems and Fujifilm expanding their presence. Local manufacturers are also emerging, contributing to market dynamics. The region's growth is further supported by collaborations between healthcare providers and technology companies, aiming to improve diagnostic capabilities and patient outcomes. ### Middle East and Africa : Developing Market with Opportunities The Middle East and Africa Elastography Imaging Market, valued at 0.71 billion, is gradually developing, driven by increasing investments in healthcare infrastructure and rising awareness of advanced imaging technologies. Governments in the region are focusing on improving healthcare services, which is expected to boost the adoption of elastography imaging solutions. The demand for non-invasive diagnostic methods is growing, particularly in countries like UAE and South Africa. The competitive landscape is characterized by a mix of global and local players, with companies like Mindray and Samsung Medison making significant inroads. The region presents opportunities for growth, particularly as healthcare systems evolve and the demand for advanced diagnostic tools increases. Collaborative efforts between governments and private sectors are essential for fostering market development. ## Competitive Benchmarking The Elastography Imaging Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for non-invasive diagnostic techniques. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips (NL) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. GE Healthcare (US) emphasizes the integration of artificial intelligence (AI) in its elastography solutions, aiming to improve diagnostic accuracy and streamline workflows. Siemens Healthineers (DE) is actively pursuing regional expansion, particularly in emerging markets, to capitalize on the growing healthcare infrastructure. Meanwhile, Philips (NL) is concentrating on [digital transformation](https://www.marketresearchfuture.com/reports/digital-transformation-market-8685), leveraging cloud-based platforms to enhance data accessibility and patient management, thereby shaping a competitive environment that prioritizes technological integration and customer-centric solutions. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and optimize supply chains. The market appears moderately fragmented, with several players vying for market share, yet the collective influence of major companies is significant. This competitive structure fosters innovation, as companies strive to differentiate their offerings through advanced technology and improved service delivery. In November 2025, Siemens Healthineers (DE) announced a strategic partnership with a leading AI firm to develop next-generation elastography imaging solutions. This collaboration is poised to enhance the capabilities of their imaging systems, potentially leading to more accurate and efficient diagnostic processes. The strategic importance of this partnership lies in its potential to position Siemens as a leader in AI-driven imaging technologies, thereby attracting a broader customer base. In October 2025, GE Healthcare (US) launched a new elastography imaging system that incorporates real-time data analytics. This innovation is expected to significantly improve the speed and accuracy of diagnoses, addressing a critical need in the market. The launch underscores GE's commitment to leveraging cutting-edge technology to enhance patient outcomes, which may strengthen its competitive position in the elastography segment. In September 2025, Philips (NL) expanded its elastography imaging portfolio by acquiring a startup specializing in advanced imaging algorithms. This acquisition is likely to bolster Philips' technological capabilities, enabling the company to offer more sophisticated imaging solutions. The strategic move reflects Philips' focus on enhancing its product offerings through innovation, which could lead to increased market share and customer loyalty. As of December 2025, current competitive trends in the Elastography Imaging Market are heavily influenced by digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on technological advancement, innovation, and supply chain reliability. This transition suggests that companies that prioritize these elements will likely emerge as leaders in the market. ## Recent News & Developments The Elastography Imaging Market has seen significant developments recently, particularly with advancements in ultrasound technologies from companies such as Samsung Medison and Siemens Healthineers. In September 2023, GE HealthCare did indeed enhance its ultrasound portfolio's elastography capabilities. The company illustrated improvements to its LOGIQ E10 and Venue Go systems, which incorporate sophisticated 2D shear wave and strain elastography technologies to facilitate liver, breast, and musculoskeletal evaluations. GE HealthCare's commitment to improving the accuracy of disease detection through the use of non-invasive imaging modalities is reflected in these updates. Through the implementation of the DeepInsight AI engine in its ARIETTA ultrasound systems, Fujifilm has maintained its commitment to enhancing its elastography capabilities. Although AI-driven elastography enhancements were not explicitly announced in September 2023, the company did emphasize them at medical imaging conferences in late 2023, such as RSNA and ECR. Particularly for the quantification of thyroid rigidity and the staging of liver fibrosis, these enhancements are comprised of image optimization algorithms. Esaote unveiled new features in its MyLab X9 and MyLab Sigma ultrasound platforms in July 2023. These features were designed to improve real-time elastography for liver and musculoskeletal applications. With an emphasis on high-demand applications such as liver fibrosis staging, Esaote has developed compact, AI-powered ultrasound systems that are designed for hospital and ambulatory use. ## Report Scope | MARKET SIZE 2024 | 12.61(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 14.01(USD Billion) | | MARKET SIZE 2035 | 40.37(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.16% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | GE Healthcare (US), Philips (NL), Siemens Healthineers (DE), Canon Medical Systems (JP), Hitachi Medical Systems (JP), Esaote (IT), Fujifilm (JP), Mindray (CN), Samsung Medison (KR) | | Segments Covered | Application, Technology, End User | | Key Market Opportunities | Advancements in non-invasive diagnostic techniques drive growth in the Elastography Imaging Market. | | Key Market Dynamics | Technological advancements in elastography imaging drive competitive dynamics and enhance diagnostic capabilities across healthcare sectors. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Elastography Imaging Market?** A: The Elastography Imaging Market was valued at 12.61 USD Billion in 2024. **Q: What is the projected market size for the Elastography Imaging Market by 2035?** A: The market is projected to reach 40.37 USD Billion by 2035. **Q: What is the expected CAGR for the Elastography Imaging Market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 11.16%. **Q: Which companies are considered key players in the Elastography Imaging Market?** A: Key players include GE Healthcare, Philips Healthcare, Siemens Healthineers, and Canon Medical Systems. **Q: What are the primary applications of elastography imaging?** A: Primary applications include Liver Imaging, Breast Imaging, Thyroid Imaging, Musculoskeletal Imaging, and Cardiac Imaging. **Q: How does the market for Liver Imaging compare to other applications?** A: Liver Imaging is projected to grow from 3.78 USD Billion to 12.06 USD Billion by 2035. **Q: What technologies are utilized in elastography imaging?** A: Technologies include Ultrasound Elastography, Magnetic Resonance Elastography, and Computed Tomography Elastography. **Q: What is the expected growth for Ultrasound Elastography by 2035?** A: Ultrasound Elastography is expected to grow from 3.78 USD Billion to 12.0 USD Billion by 2035. **Q: Which end-use segments are driving the Elastography Imaging Market?** A: End-use segments include Hospitals, Diagnostic Imaging Centers, and Research Institutions. **Q: What is the projected growth for the Diagnostic Imaging Centers segment?** A: The Diagnostic Imaging Centers segment is expected to grow from 3.78 USD Billion to 12.05 USD Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070*